NOREL AD Trademark

Trademark Overview

On Tuesday, December 31, 2024, a trademark application was filed for NOREL AD with the United States Patent and Trademark Office. The USPTO has given the NOREL AD trademark a serial number of 98930521. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, April 1, 2025. This trademark is owned by U.S. Pharmaceutical Corporation. The NOREL AD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for sinus and allergy relief, for human consumption, not for animals
norel ad

General Information

Serial Number98930521
Word MarkNOREL AD
Filing DateTuesday, December 31, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateTuesday, April 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for sinus and allergy relief, for human consumption, not for animals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 31, 2024
Primary Code005
First Use Anywhere DateSaturday, March 31, 2012
First Use In Commerce DateSaturday, March 31, 2012

Trademark Owner History

Party NameU.S. Pharmaceutical Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDecatur, GA 30035

Trademark Events

Event DateEvent Description
Tuesday, December 31, 2024NEW APPLICATION ENTERED
Tuesday, December 31, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 25, 2025ASSIGNED TO EXAMINER
Monday, March 31, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 31, 2025NON-FINAL ACTION WRITTEN
Monday, March 31, 2025NON-FINAL ACTION E-MAILED
Monday, March 31, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 31, 2025EXAMINERS AMENDMENT E-MAILED
Monday, March 31, 2025EXAMINER'S AMENDMENT ENTERED
Monday, March 31, 2025EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 1, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

norel human consumption animals relief allergy preparations sinus pharmaceutical